TOP STORIES

• REGULATORY Bill to Amend PAL Will Be Submitted to Diet in May, as Instructed by PM Abe: Mr Akagawa of PFSB
  April 25, 2013

• ACADEMIA RA Treatment Guidelines to Reflect Patients’ Values and Economic Considerations as Well as Evidence
  April 24, 2013

• ACADEMIA New COPD Guidelines Recommend LAMA, LABA on Equal Footing
  April 23, 2013

• BUSINESS Pfizer-Mylan Pair’s Japan Generic Share at 2.8%, Aspire for Bigger Slice of Market
  April 22, 2013

• BUSINESS Tug-of-War over “Conflicts of Interest” (2): “Diovan Scandal” Brings Renewed Attention to COI
  April 19, 2013

• BUSINESS Novo Nordisk Ups Efforts in Basal Insulin Market, Pits Tresiba against Lantus
  April 18, 2013

• ORGANIZATION Tug-of-War over “Conflicts of Interest” (1): Drug Makers, Doctors Remain Divided
  April 18, 2013

• BUSINESS Teijin Pharma Hopes to Derive 50%-Plus of Sales from New Drugs by around 2016: Pres. Uno
  April 17, 2013

• REGULATORY Growing Concern Over Return to Brand Names for Generics with Advent of Generic Versions of Combination Drugs
  April 16, 2013

• REGULATORY Supreme Court Rejects Damage Claims in Iressa Suits; Govt, AZ Win 8-Year Battle
  April 15, 2013

• BUSINESS 11 Drug Makers to Increase, 11 to Decrease Hiring Next Year; Mid-Sized Companies Most Optimistic on Hiring
  April 15, 2013

• REGULATORY Generic Roadmap: CSIMC Bill Payer Rep Says New 60% Target Could “Decelerate” Shift
  April 12, 2013

• BUSINESS Eisai Announces Organizational Reforms; “We Won’t Allow Generics to Overwhelm AD Market”: President Naito
  April 12, 2013

• BUSINESS Shire Enters Japan Full Force, Six Products to Be Launched in Five Years
  April 11, 2013

• BUSINESS Amgen Plans New Product Debuts in Japan by 2016, Pins Hopes on Hyperlipidemia Drug
  April 10, 2013

• BUSINESS Rubella Epidemic Triggers Vaccine Shipment Adjustments at Drug Makers
  April 9, 2013

• REGULATORY MHLW Unveils Generic Roadmap, Aims for 60%-Share by FY2017
  April 8, 2013

• BUSINESS Takeda to Successively File 2 New Diabetes Drugs in Japan
  April 5, 2013

• BUSINESS Protected Drugs Represent More than 50% of Bayer Yakuhin Sales in 2012, Over 60% Eyed by 2014: Pres. Brunn
  April 4, 2013

• BUSINESS Presidents of Pharmaceutical Companies Stress Globalization, Compliance in Welcoming Ceremonies for New Employees
  April 4, 2013

ページ

• « 先頭
• ‹ Prev
• …
• 220
• 221
• 222
• 223
• 224
• 225
• 226
• 227
• 228
• …
• Next ›
• 最終 »